Parallel Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$266K Sell
817
-45
-5% -$14.7K 0.01% 875
2025
Q1
$233K Buy
862
+31
+4% +$8.37K 0.01% 889
2024
Q4
$196K Buy
831
+292
+54% +$68.7K ﹤0.01% 938
2024
Q3
$148K Buy
539
+140
+35% +$38.5K ﹤0.01% 1058
2024
Q2
$96.9K Buy
399
+156
+64% +$37.9K ﹤0.01% 1199
2024
Q1
$36.3K Buy
243
+32
+15% +$4.78K ﹤0.01% 1650
2023
Q4
$40.4K Sell
211
-16
-7% -$3.06K ﹤0.01% 1540
2023
Q3
$40.2K Buy
227
+18
+9% +$3.19K ﹤0.01% 1503
2023
Q2
$39.7K Buy
209
+27
+15% +$5.13K ﹤0.01% 1520
2023
Q1
$36.5K Sell
182
-12
-6% -$2.4K ﹤0.01% 1540
2022
Q4
$46.1K Buy
194
+9
+5% +$2.14K ﹤0.01% 1308
2022
Q3
$37K Buy
185
+12
+7% +$2.4K ﹤0.01% 1380
2022
Q2
$25K Sell
173
-38
-18% -$5.49K ﹤0.01% 1549
2022
Q1
$35K Sell
211
-55
-21% -$9.12K ﹤0.01% 1437
2021
Q4
$45K Sell
266
-84
-24% -$14.2K ﹤0.01% 1360
2021
Q3
$66K Buy
350
+167
+91% +$31.5K ﹤0.01% 1137
2021
Q2
$31K Sell
183
-9
-5% -$1.53K ﹤0.01% 1433
2021
Q1
$27K Buy
192
+61
+47% +$8.58K ﹤0.01% 1434
2020
Q4
$17K Buy
131
+18
+16% +$2.34K ﹤0.01% 1525
2020
Q3
$16K Buy
113
+3
+3% +$425 ﹤0.01% 1504
2020
Q2
$16K Buy
110
+24
+28% +$3.49K ﹤0.01% 1490
2020
Q1
$9K Buy
86
+3
+4% +$314 ﹤0.01% 1626
2019
Q4
$10K Buy
83
+21
+34% +$2.53K ﹤0.01% 1705
2019
Q3
$5K Buy
62
+54
+675% +$4.36K ﹤0.01% 1883
2019
Q2
$1K Sell
8
-26
-76% -$3.25K ﹤0.01% 2150
2019
Q1
$3K Buy
34
+10
+42% +$882 ﹤0.01% 1925
2018
Q4
$1K Sell
24
-70
-74% -$2.92K ﹤0.01% 1969
2018
Q3
$8K Buy
94
+17
+22% +$1.45K ﹤0.01% 1503
2018
Q2
$7K Sell
77
-5
-6% -$455 ﹤0.01% 1455
2018
Q1
$10K Buy
82
+13
+19% +$1.59K ﹤0.01% 1243
2017
Q4
$9K Hold
69
﹤0.01% 1325
2017
Q3
$9K Buy
+69
New +$9K ﹤0.01% 1314